For the tumor-associated macrophage populations, this analysis revealed high expression of the alternative activation markers Arg1, Fizz1, and Mrc1, which coincided with reduced mRNA levels of the classically activated marker Nos2 (Fig. 5c). The gene discussed is MRC1; the disease is neoplasm.